Prostate-Specific Antigen Levels Posttreatment May Not Predict Overall Survival

THURSDAY, Aug. 31, 2023 -- Treatments that reduce the risk for biochemical recurrence (BCR) based on rising prostate-specific antigen levels after radiotherapy do not necessarily improve a patient’s long-term overall survival (OS), according to a...